Clinical Trials Browser

Advanced Lung Neuroendocrine Tumor

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma

Adenoma, Islet Cell, Neoplasm Metastasis, Neuroendocrine Tumors

Carcinoma, Renal Cell, von Hippel-Lindau Disease

Triple Negative Breast Neoplasms

Unilateral Breast Neoplasms, Breast Neoplasms, Recurrence

Metastatic Digestive System Neuroendocrine Tumor G1

Neoplasm Metastasis

Breast Neoplasms, Triple Negative Breast Neoplasms

Advanced Breast Cancer

Gastro-enteropancreatic neuroendocrine tumor, Carcinoid Tumor, Adenoma, Islet Cell, Neuroendocrine Tumors

Breast Neoplasms

Breast Neoplasms

Thymus Neoplasms, Neuroendocrine Tumors

Diffuse Intrinsic Pontine Glioma

Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Tuberous Sclerosis, Neuroendocrine Tumors

Breast Neoplasms

Neoplasm Metastasis

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Gastroenteropancreatic Neuroendocrine Tumors

Neoplasm Metastasis

Glioblastoma, Recurrence

Clinical Trials

Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

MOMENTUM-1

STELLAR-311

MK-6482-043

FUSCC Refractory TNBC Platform Study (FUTURE2.0)

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer

EVOLVE-BDT

ADELA

ACTION-1

LITESPARK-029

Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer

LEVEL

Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma

BIOMEDE 2

Sapu003 in Advanced mTOR-sensitive Solid Tumors

A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and Metastatic Breast Cancer

GERTRUDE

ESMART

A Phase Ib/II Study to Evaluate Multiple Combination Therapies of FWD1802 in Patients With ER+/HER2- BC

ELEVATE

Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer

A Study of SIM0270 Combined With Everolimus vs. Treatment of Physician's Choice in Patients With ER+/HER2- Advanced Breast Cancer (SIMRISE)

LUMEN-1

Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors

MOST plus

Pilot Trial for Treatment of Recurrent Glioblastoma